Celleron Therapeutics
About us

Celleron Therapeutics is an oncology healthcare company dedicated to developing unique cancer therapies and technologies that improve the performance of regular cancer treatments.

Celleron’s current pipeline includes three clinical products and several pre-clinical stage opportunities that target key pathways involved with tumour cell growth.

A key value driver reflects Celleron’s ability to derive functionally important biomarkers that can be exploited to predict the sensitivity of tumours to drugs, and thereby stratify patients into improved responder groups.

Celleron has adopted an aggressive business model towards reaching critical mass and a sustainable product portfolio.

Celleron has secured several pharmaceutical partners to progress its product portfolio.

Celleron is currently located in Oxford, UK, with a close relationship to the University of Oxford and the new Oxford Institute of Cancer Medicine.